Gene editing of patients’ blood stem cells can potentially cure many blood disorders. But introducing targeted edits into these cells has been challenging, and the edits aren’t always stable once the cells engraft in the bone marrow. Researchers now report a CRISPR approach that overcomes these technical challenges.
Researchers optimize gene editing for SCD and beta thalassemia
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024
About admin
Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge.
Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →